Siemens Makes First Molecular Dx Buy In Nine Years
This article was originally published in The Gray Sheet
The firm's health-care division bought private next-generation sequencing firm NEO New Oncology for an undisclosed amount.
You may also be interested in...
Siemens' medical unit solidified its status July 25 as the only company offering a comprehensive suite of both imaging and in vitro diagnostic products with its $7 billion acquisition of Dade Behring
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
Illumina announced on 21 September it will buy back Grail, which is planning to commercialize its multi-cancer early detection blood test Galleri in 2021. See what Illumina’s CEO Francis deSouza said about it here.